Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsA malaria drug taken by US President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare workers, according to clinical trial results published on Wednesday.
The controversial French professor who believes the anti-malaria drug chloroquine can help beat the coronavirus has claimed that a new study he has conducted confirms its "efficiency" at combating the virus.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.